Researchers from Duke University School of Medicine Discuss Research in Parkinson's Disease (G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage)

    Prensa/medios de comunicación

    Período18 mar. 2024

    Cobertura de los medios

    1

    Cobertura de los medios

    • NombreResearchers from Duke University School of Medicine Discuss Research in Parkinson's Disease (G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage)
      Nombre/canal del medio de comunicaciónGenomics & Genetics Daily
      Fecha18/03/24
      PersonasClaudia Paulina Gonzalez Cuervo
    Ver todos 1
    Ver menos